A novel epitope-presenting thermostable scaffold for the development of highly specific insulin-like growth factor-1/2 antibodies

被引:2
|
作者
Peess, Carmen [1 ]
Scholz, Christian [2 ]
Casagolda, David [3 ]
Duefel, Hartmut [1 ]
Gerg, Michael [1 ]
Kowalewsky, Frank [1 ]
Bocola, Marco [5 ]
von Proff, Leopold [3 ]
Goller, Sabine [3 ]
Kloeppel-Swarlik, Heidi [4 ]
Hoppe, Alessandra [4 ]
Schraeml, Michael [3 ]
机构
[1] Roche Diagnost GmbH, Antibody Dev, D-82377 Penzberg, Germany
[2] Roche Diagnost GmbH, Prot Design, D-82377 Penzberg, Germany
[3] Roche Diagnost GmbH, Enzyme & Prot Technol, Nonnenwald 2, D-82377 Penzberg, Germany
[4] Roche Diagnost GmbH, Endocrinol Dis 3, D-82377 Penzberg, Germany
[5] Rhein Westfal TH Aachen, Lehrstuhl Biotechnol, D-52074 Aachen, Germany
关键词
antibody; antigen presentation; chaperone; insulin-like growth factor (IGF); protein engineering; antigen mimic; FK-506 binding protein; FKBP domain; immunogen; I IGF-I; PROLYL-ISOMERASE; STRUCTURAL HOMOLOGY; CRYSTAL-STRUCTURE; FORCE-FIELD; DOMAIN; SLYD; PROTEINS; POLYPEPTIDES; INSERTIONS;
D O I
10.1074/jbc.RA119.007654
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
High sequence and structural homology between mature human insulin-like growth factors IGF-1 and IGF-2 makes serological discrimination by immunodiagnostic IGF tests a challenging task. There is an urgent need for highly specific IGF-1 and IGF-2 antibodies, yet only a short sequence element, i.e. the IGF loop, provides enough difference in sequence to discriminate between the two molecules. We sought to address this unmet demand by investigating novel chimeric immunogens as carriers for recombinant peptide motif grafting. We found Thermus thermophilus sensitive to lysis D (SlyD) and Thermococcus gammatolerans SlyD FK-506-binding protein (FKBP) domains suitable for presentation of the predefined epitopes, namely the IGF-1 and IGF-2 loops. Chimeric SlyD-IGF proteins allowed for the development of exceptionally specific IGF-1 and IGF-2 monoclonal antibodies. The selected antibodies bound with high affinity to the distinct IGF epitopes displayed on the protein scaffolds, as well as on the mature human IGF isoforms. The respective SlyD scaffolds display favorable engineering properties in that they are small, monomeric, and cysteine-free and can be produced in high yields in a prokaryotic host, such as Escherichia coli. In conclusion, FKBP domains from thermostable SlyD proteins are highly suitable as a generic scaffold platform for epitope grafting.
引用
收藏
页码:13434 / 13444
页数:11
相关论文
共 50 条
  • [1] SlyD: A novel epitope-presenting thermostable scaffold for the development of highly specific IGF-1/-2 antibodies
    Peess, C.
    Vallribera, D. Casagolda
    Gerg, M.
    Kowalewsky, F.
    Scholz, C.
    Bocola, M.
    Von Proff, L.
    Goller, S.
    Kloeppel-Swarlik, H.
    Hoppe, A.
    Schraeml, M.
    CLINICA CHIMICA ACTA, 2019, 493 : S341 - S341
  • [2] Insulin-like growth factor-1
    Colbert, LH
    Rosen, CJ
    Goodpaster, BH
    Newman, AB
    Kritchevsky, SB
    Satterfield, S
    Kanaya, AM
    Taaffe, DR
    Harris, TB
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2004, 52 (11) : 1962 - 1963
  • [3] Development of Nasal Insulin-Like Growth Factor-1 as a Novel Treatment for Migraine
    Kraig, R. P.
    Won, L.
    HEADACHE, 2019, 59 : 164 - 164
  • [4] Insulin, Insulin-like Growth Factor-1 and Neurodegeneration
    Cifarelli, Vincenza
    Hays, Drew
    Hursting, Stephen D.
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2011, 9 (03) : 422 - 424
  • [5] Insulin-Like Growth Factor-1 and Neuroinflammation
    Labandeira-Garcia, Jose L.
    Costa-Besada, Maria A.
    Labandeira, Carmen M.
    Villar-Cheda, Begona
    Rodriguez-Perez, Ana I.
    FRONTIERS IN AGING NEUROSCIENCE, 2017, 9
  • [6] Growth Hormone and Insulin-Like Growth Factor-1
    Nicholls, Adam R.
    Holt, Richard I. G.
    SPORTS ENDOCRINOLOGY, 2016, 47 : 101 - 114
  • [7] Doxorubicin Impairs the Insulin-Like Growth Factor-1 System and Causes Insulin-Like Growth Factor-1 Resistance in Cardiomyocytes
    Fabbi, Patrizia
    Spallarossa, Paolo
    Garibaldi, Silvano
    Barisione, Chiara
    Mura, Marzia
    Altieri, Paola
    Rebesco, Barbara
    Monti, Maria Gaia
    Canepa, Marco
    Ghigliotti, Giorgio
    Brunelli, Claudio
    Ameri, Pietro
    PLOS ONE, 2015, 10 (05):
  • [8] Serum levels of insulin-like growth factor-1 and insulin-like growth factor-1 binding proteins after radical prostatectomy
    Bubley, GJ
    Balk, SP
    Regan, MM
    Duggan, S
    Morrissey, ME
    Dewolf, WC
    Salgami, E
    Mantzoros, C
    JOURNAL OF UROLOGY, 2002, 168 (05): : 2249 - 2252
  • [9] Insulin and insulin-like growth factor-1 action on human skeletal muscle: Preferential effects of insulin-like growth factor-1 in type 2 diabetic subjects
    Ciaraldi, TP
    Carter, L
    Rehman, N
    Mohideen, P
    Mudaliar, S
    Henry, RR
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2002, 51 (09): : 1171 - 1179
  • [10] Insulin-like growth factor-1 and insulin-like growth factor binding proteins in cerebrospinal fluid during the development of mouse embryos
    Salehi, Zivar
    Mashayekhi, Farhad
    Naji, Mohammad
    Pandamooz, Sareh
    JOURNAL OF CLINICAL NEUROSCIENCE, 2009, 16 (07) : 950 - 953